Influence of sex hormones on prostate volume in men on hemodialysis

Journal of Andrology

Volumn 21, Issue 2, 2000, Pages 258-261

  Hayami, Shinsuke ^a,c   Sasagawa, Isoji ^a,b   Nakada, Teruhiro ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Estradiol; Testosterone

Indexed keywords

ESTRADIOL; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; HEMODIALYSIS; HORMONAL REGULATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; ESTRADIOL; HUMANS; MALE; MIDDLE AGED; PROSTATE; RENAL DIALYSIS; TESTOSTERONE;

EID: 0033998695     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barrack ER, Berry SJ. DNA synthesis in the canine prostate. Effects of androgen and estrogen treatment. Prostate. 1987;10:45-56.
2. Berry SJ, Coffey D, Ewing LL. Effects of aging on prostate growth in beagles. Am J Physiol. 1986;250:R1039-R1046.
3. Chryssicopoulos A, Koutsikos D, Kapetanaki A, Agroyannis B, Tzanatos H, Rammos G, Fourtounas C, Kopelias I, Bossiolis B, Darema M, Zourlas PA. Evaluation of the hypothalamic-pituitary axis in uremic males using dynamic tests. The possible role of testicular inhibin. A preliminary report. Ren Fail. 1996;18:911-921.
4. Daniell HW. Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy. J Urol. 1993;149:315-317.
5. Diagnostics Products Corporation. Coat-a-Count® Estradiol. Technical Insert. Los Angeles, Calif: Diagnostic Products, 1995.
6. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Gordestien F, Stamfer MJ. A prospective study of plasma hormone levels, non-hormonal factors, and development of benign prostate hyperplasia. Prostate. 1995;26:40-49.
7. Geller J. Overview of benign prostatic hypertrophy. Urology (Suppl). 1989;34:54-63.
8. Handelsman DJ. Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation. Endocr Rev. 1985;6:151-182.
9. Handelsman DJ, Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am. 1993;22:145-161.
10. Jin B, Turner L, Walters WAW, Handelsman DJ. Androgen or estrogen effects on human prostate. J Clin Endocrinol Metab. 1996;81:4290-4295.
11. Kliewer EV. Benign prostatic hyperplasia morbidity and mortality among immigrants in Australia and Canada. Prostate. 1996;28:211-218.
12. Kokot F, Wiecek A, Schmidt-Gayk H, Marcinkowski W, Gilge U, Heodland A, Rudka R, Trembecki J. Function of endocrine organs in haemodialyzed patients of long-term erythropoietin therapy. Artif Organs. 1995;19:428-435.
13. Kumar VL, Wadhwa SN, Kumar V, Farooq A. Androgen, estrogen and progesterone receptor contents and serum hormone profiles in patients with benign prostatic hypertrophy and carcinoma of the prostate. J Surg Oncol. 1990;44:122-128.
14. Levine AC, Kirschenbaum A, Gabrilove JL. The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia. Mt Sinai J Med. 1997;64:20-25.
15. Lim VS, Fang VS. Restoration of plasma testosterone levels in uremic men with clomiphene citrate. J Clin Endocrinol Metab. 1976;43: 1370-1377.
16. Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for screening - part II. Accuracy of in vitro and in vivo techniques. Radiology. 1991;179:49-53.
17. Mastrogiacomo I, De Besi L, Zucchetta P, Serafini E, La Greca G, Gasparotto ML, Lorenzi S, Dean P. Male hypogonadism of uremic patients on hemodialysis. Arch Androl. 1988;20:171-175.
18. Matumori N, Tsukamoto T, Kumamoto Y, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Age-related differences internal prostatic architecture on transrectal ultrasonography. Results of a community based survey in Japan. J Urol. 1997;157:1718-1722.
19. Ooi DS, Donnelly JG. More on the analog free-testosterone assay. Clin Chem. 1999;45:714-716.
20. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on volume of benign prostate hyperplasia. J Urol. 1991;145:405-409.
21. Sanda MG, Beaty TH, Stutzman RE, Childs B, Walsh PC. Genetic susceptibility of benign prostatic hyperplasia. J Urol. 1994;152:115-119.
22. Sasagawa I, Adachi Y, Sawamura T, Iijima Y, Hayami S, Kubota Y, Nakada T, Manaka Y, Watanabe M, Yamaguchi K. Serum levels of total and free testosterone in men undergoing hemodialysis. Arch Androl. 1998;40:153-158.
23. Soygur T, Kupeli B, Aydos K, Kupeli S, Arikan N, Muftuoglu YZ. Effect of obesity on prostatic hyperplasia. Its relation to sex steroid levels. Int Urol Nephrol. 1996;28:55-59.
24. Suzuki K, Ito K, Ichinose Y, Kurokawa K, Suzuki T, Imai K, Yamanaka H, Honma S. Endocrine environment of benign prostatic hyperplasia. Prostate size and volume are correlated with serum estrogen concentration. Scand J Urol Nephrol. 1995;29:65-68.
25. Taussky HH. Creatinine and creatine in urine and serum. In: Seligson D, eds. Standard Methods of Clinical Chemistry. Vol 3. New York: Academic Press Inc; 1961.
26. Thomas JA, Keenan EJ. Effects of estrogens on the prostate. J Androl. 1994;15:97-99.
27. Trachtenberg J, Hicks LL, Walsh PC. Androgen and estrogen receptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest. 1980;65:1051-1059.
28. Winters SJ, Kelley DE, Goodpaster B. The analog free testosterone assay: are the results in men clinically useful? Clin Chem. 1998;44:2178-2182.